The Association between Cyclo-oxygenase Inhibitor Medications and Clinical Relapse in Inflammatory Bowel Disease: Review of Current Perspectives
Journal Title: Journal of Advances in Medicine and Medical Research - Year 2015, Vol 5, Issue 4
Abstract
Background: Patients with inflammatory bowel disease (IBD) often have associated conditions which may benefit from treatment with non-steroidal anti-inflammatory drugs (NSAIDs) or selective cyclo-oxygenase-2 (COX-2) inhibitors. However, evidence has suggested there may be an association between COX- inhibition and relapse in IBD, which leads to clinicians being reluctant to prescribe these agents. Aims: The aim of this review is to review the possible biological mechanisms, linking NSAIDs and IBD-relapse and current knowledge on the possible association of NSAIDs and clinical relapse in IBD. Results: IBD relapse due to NSAID use is most likely due to prostaglandin inhibition via dual COX-inhibition, although the topical effect of NSAIDs on the intestine may also play a role. The evidence for an association between NSAIDs and IBD relapse is contradictory and generally weak, but it is likely a small percentage of patients relapse when taking NSAIDs, but it is not known which patients are at risk. Mixed results have also been obtained from studies examining COX-2 selective agents; although a single randomized controlled-trial showed that celecoxib is safe in ulcerative colitis in the short term. Conclusions: At present the data are contradictory and most published studies have serious flaws. Overall the association between use of NSAIDs and IBD-relapse seems rather weak, Cyclo-oxygenase inhibitors should not be withheld from stable IBD patients, if clinically indicated and appropriate cautions and monitoring are used. Celecoxib would seem a sensible first choice. Further studies are needed to help identify which patients are at risk of relapse with NSAIDs.
Authors and Affiliations
Abigail Hensley, Ian L. P. Beales
Evaluation of Anemia Management in Hemodialysis Patients in Gezira Hospital, in Sudan
Anemia of kidney disease is a common but under recognized co-morbid condition that is known to place patients at greater risk of hospitalization, cognitive impairment, cardiovascular diseases and even death. Aims: The a...
Prevalence of Exfoliative and Toxic Shock Syndrome Toxin Genes in Methicillin-resistant Staphylococcus aureus Strains Isolated from Clinical Specimens in Makkah, Saudi Arabia
The emergence of methicillin-resistant Staphylococcus aureus (MRSA) strains possessing virulence genes encoding such toxins as exfoliative toxins (ETs), toxic shock syndrome toxin-1 (TSST-1), is worrying, especially in r...
The Efficacy of Quality of Life Therapy on Mental Health in the Families of Patients with Chronic Psychiatric Disorders
Background and Aim: Caring for and living with patients with chronic psychiatric disorders may cause high levels of stress for their families. The aim of this study was to investigate the efficacy of quality of life ther...
Association between Body Mass Index (BMI) and Glycemic Control in Patients with Type 2 Diabetes Mellitus Admitted in a Rural Teaching Hospital in the State of Kerala, India – A Pilot Study
Aim: To determine body mass index (BMI) of all hospitalized type 2 diabetic patients and its association with HbA1C value Study Design: Pilot cross-sectional study. Place and Duration of Study: Department of Medicine, M...
The Role of Socio-economic Factors in Abandonment of Cancer Treatment among Paediatric Patients in Jos Nigeria
The outcome of pediatric cancer therapy in the developed country is good however in Developing countries like Nigeria pediatric cancer treatment is characterized by late presentation, presences of co-morbidities and outr...